The Medical Letter on Drugs and Therapeutics
In Brief: Herbal Warning
Download PDF:   US English
Med Lett Drugs Ther. 2008 Feb 11;50(1279):9
 Select a term to see related articles  2008   alprazolam   Aristolochic acid   Coumadin   Dietary supplements   Estrogen   February 11   Herbal Warning   herbals   Herbs   In brief   Indocin   indomethacin   Issue 1279   Lovastatin   Mevacor   Page 9   phosphodiesterase-5 inhibitor   sildenafil   Viagra   volume 50   warfarin   weight loss   Xanax 

The FDA recently advised health care professionals and consumers not to use a number of dietary supplements found to contain the phosphodiesterase-5 inhibitor sildenafil (Viagra) or an analog of the drug ( Although the effects of sildenafil may be noticeable (in men), the presence of other, possibly more toxic adulterants in dietary supplements may be more difficult or impossible to detect.

Other drugs previously found in dietary supplements have included lovastatin (Mevacor, and others), estrogen, alprazolam (Xanax, and others), indomethacin (Indocin, and others) and warfarin (Coumadin, and others). Aristolochic acid in Chinese herbal weight loss products caused acute renal failure in about 100 women in Belgium; at least 70 of them required dialysis or transplantation, and at least 18 developed urothelial cancer (Med Lett Drugs Ther 2002; 44:84).

Dietary supplements do not require FDA approval before marketing. The agency does have the power to remove mislabeled or adulterated products from store shelves, but the burden of discovery and proof is entirely on the government.

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article
arrow to next article